Abstract
See Article on Page 41 The sustained virological response (SVR) of the combination of both pegylated interferon alfa (PegIFN) and ribavirin (RBV) in patients with chronic hepatitis C virus (HCV) infection is heterogeneous. 1 The therapeutic approach has been more individualized to obtain the better outcomes of patients with chronic HCV infection, and clinicians need to know the factors for predicting SVR. 2 The viral factors are
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
